Human EPCA2(Early Prostate Cancer Antigen 2) ELISA Kit

In the realm of EPCA2, the early prostate cancer antigen 2, our Human EPCA2 ELISA Kit (EH1781) is the epitome of precision and efficiency. This meticulously designed kit empowers researchers to accurately quantify EPCA2 levels in human samples, thereby fortifying the integrity and trustworthiness of research data.
Exceptional Precision: The EH1781 kit guarantees the highest level of precision and accuracy in quantifying EPCA2. This ensures that your research findings are robust and reliable, providing a solid foundation for scientific inquiry.
Broad Detection Range: This kit accommodates a wide range of sample concentrations, making it ideal for diverse research applications related to EPCA2, whether exploring its utility in prostate cancer diagnosis or other areas.
User-Friendly Interface: The kit simplifies laboratory procedures with clear and intuitive protocols, optimizing the research process and user experience.
Time Efficiency: Engineered for efficiency, EH1781 minimizes laboratory work time, ensuring the rapid generation of research results and enhancing overall research productivity.
Researching EPCA2 with EH1781 provides a dependable, precise, and efficient tool for your scientific inquiries. Whether your focus is on cancer diagnosis, biomarker research, or other aspects, this kit ensures the trustworthiness of your data.

Product Name

Human EPCA2(Early Prostate Cancer Antigen 2) ELISA Kit

Alias

EPCA2 ELISA Kit

Detection Method

Sandwich ELISA, Double Antibody

Application

EPCA2 ELISA Kit allows for the in vitro quantitative determination of EPCA2 concentrations in serum, plasma, tissue homogenates and other biological fluids.

Size

96T

Range

6.25-400ng/ml

Sensitivity

< 3.75ng/ml

Species

Human

Standard Curve

Storage

2-8 ℃ for 6 months

Recovery

Matrices listed below were spiked with certain level of EPCA2 and the recovery rates were calculated by comparing the measured value to the expected amount of EPCA2 in samples.

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of EPCA2 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

CV(%)

Intra-Assay: CV<8%

Inter-Assay: CV<10%

Note

For Research Use Only